CD4 and tuberculosis: Thus, IFN-γ/IL-17-producing multifunctional CD4+ T-cells are determinants of protective efficacy of TB subunit vaccines, and HSP90-E6/CIA05 is an excellent TB vaccine candidate that effectively induces such a response.